The field of gastroenterology and hepatology is experiencing a tremendous explosion of scientific knowledge and translational advances. It is a privilege to work in this field and to nurture the next generation of researchers and clinicians who will answer many critical questions and lessen the burden of digestive disease globally. Gastroenterology and hepatology are a rapidly growing field with many opportunities for research and clinical practice.

The field is at the forefront of understanding the gut-brain axis and the role of the microbiome in human health. Gastroenterologists and hepatologists are involved in diagnosing and treating a wide range of digestive diseases, including inflammatory bowel disease, liver disease, and pancreatic cancer. The field is committed to improving the lives of patients with digestive diseases and to finding cures for these diseases.

Professor Emad El-Omar from the University of New South Wales wrote an editorial welcoming eGastroenterology to the world of science communication and scientific research, as well as join BMJ Journals family.

If you enjoy the content we create and would like to support us, please consider becoming a patron on Patreon! By joining our community, you’ll gain access to exclusive perks such as early access to our latest content, behind-the-scenes updates, and the ability to submit questions and suggest topics for us to cover. Your support will enable us to continue creating high-quality content and reach a wider audience.

Join us on Patreon today and let’s work together to create more amazing content! https://www.patreon.com/ScientificInquirer

“The new journal, eGastroenterology, has been launched to accelerate research in gastroenterology and hepatology,” said El-Omar. “It seeks to benefit patients globally through communicating the best science and clinical practices. By focusing on the application of real-world data, it will provide high-level evidence and guide clinical practice.”

eGastroenterology will welcome observational studies, randomized controlled trials, genetic association studies, systematic reviews and meta-analyses.

“Scientific publishing is a great privilege and a major responsibility,” said El-Omar. “Journals and their editorial teams must ensure they publish work of the highest scientific integrity and quality.”

The COVID-19 pandemic taught us that achieving very rapid progress in a field is possible. Enos added that we should apply the same principles for all of humanity’s challenges, including cures for cancer, antimicrobial resistance, obesity, and metabolic diseases.

In his editorial, El-Omar looked at the microbiome field, as he believes it offers enormous opportunities for making a difference in the world’s health. He bases this thinking on the scientific advances that continue unabated every day. In his opinion, the microbiome is the missing ingredient that likes a range of pathways.

With the advent of artificial intelligence and machine learning growing in influence, El-Omar believes that the translational pathway for the microbiome provides enormous potential. He looks forward to seeing more advances being published in eGastroenterology.

IMAGE CREDIT: NASA.